The global pharmaceutical cartridges market size was valued at USD 933.33 Million in 2017 and is expected to register a CAGR of 7.8% over the forecast period. Rising prevalence of chronic conditions, such as diabetes and arthritis, is expected to boost market growth over the next few years.
Various advantages offered by pharmaceutical cartridges over the traditional ones are also expected to drive the market growth over the estimated period. Some of these advantages include better damage resistance, chemical durability, and accurate drug delivery.
These cartridges also enable long-term storage without altering the chemical formulation of the drugs. Furthermore, it ensures a smoother line of operations as it reduces the risk of damages while transporting and delivering drugs. Investment by prominent companies in developing advanced pharmaceutical cartridges is anticipated to boost the application and usage of pharmaceutical cartridges.
In July 2017, drug giants Merck and Pfizer have teamed up with glass manufacturer Corning to create a solution for injectable drugs in vials and cartridges. Thus, all these instances are expected to positively impact this market over the forecast period.
Based on material type, the pharmaceutical cartridges market is segmented into glass and plastic cartridges. The glass segment led the market. Superior quality and damage resistance has increased product demand. Its precise dimensional tolerances, resistance against thermal shock, reliable integration into injection devices, and narrow cosmetic tolerances are also expected to fuel the demand for glass cartridges. The glass cartridges are further segmented into types 1, 2, and 3.
Among these, type 1 is expected to register the highest share over the forecast period owing to its wide range of applicability and high damage resistance. Plastic cartridges are segmented into Polypropylene (PP), Cyclic Olefin Copolymer (COC), Cyclic Olefin Polymer (COP), and Polyethylene (PE). Among these, polyethylene is expected to witness the fastest growth over the coming years. High resistance and easy availability are the major factors driving this segment.
North America is expected to witness the highest market share over the forecast period. Increasing prevalence of chronic diseases, such as arthritis, and obesity, in North America, are contributing towards the market growth. For instance, in 2017, as per the Centers for Disease Control & Prevention (CDC) around 30.3 Million people (9.4%) of all ages in the U.S. population suffered from diabetes and around 87.5% of adults suffered from obesity in 2015.
Such instances are anticipated to augment the demand for medication, especially, insulin for the treatment of diabetes, thereby fueling the market growth. Pharmaceutical cartridges are widely used for insulin delivery owing to their advantages, such as long-term storage and accurate dosage. Furthermore, the increased focus of companies in the U.S. are manufacturing glass cartridges due to their increasing adoption in pharmaceutical packaging will have a positive impact on the region’s growth.
Asia Pacific is expected to exhibit the fastest growth due to the high penetration of major companies in this region along with the increasing prevalence of chronic diseases. For instance, as per the International Diabetes Federation in 2017, 82.0 Million people were diagnosed with diabetes in the Southeast Asia region; among which around 72,946,400 cases of diabetes were from India.
Some of the major companies in the market are Gerresheimer AG; SCHOTT AG; West Pharmaceutical Services, Inc.; Merck KGaA; Stevanto Group; Transcoject GmbH; and Baxter International, Inc. Most of these companies have adopted strategies, such as new product development, the establishment of new manufacturing centers, and partnerships, for strengthening their market position.
For instance, in August 2018, Gerresheimer AG, established three specialist glassworks in China and two in India to meet the international and local demands for premium-quality primary packaging for liquid and solid drugs. This will help the firm in increasing its customer base in these countries.
Report Attribute |
Details |
Market size value in 2020 |
USD 1,164.34 million |
Revenue forecast in 2026 |
USD 1,834.86 million |
Growth Rate |
CAGR of 7.8% from 2018 to 2026 |
Base year for estimation |
2017 |
Historical data |
2014 – 2016 |
Forecast period |
2018 – 2026 |
Quantitative units |
Revenue in USD million and CAGR from 2018 to 2026 |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors and trends |
Segments covered |
Material type, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; U.K.; Germany; China; Japan; Mexico; Brazil; South Africa; Saudi Arabia |
Key companies profiled |
AG; SCHOTT AG; West Pharmaceutical Services, Inc.; Merck KGaA; Stevanto Group; Transcoject GmbH; Baxter International, Inc. |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue and volume growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2014 to 2026. For the purpose of this study, Grand View Research has segmented the global pharmaceutical cartridges market report on the basis of material type and region:
Material Type Outlook (Revenue, USD Million, 2014 - 2026)
Glass
Type 1
Type 2
Type 3
Plastic
Polypropylene (PP)
Cyclic Olefin Copolymer (COC)
Cyclic Olefin Polymer (COP)
Polyethylene
Regional Outlook (Revenue, USD Million, 2014 - 2026)
North America
The U.S.
Canada
Europe
The U.K.
Germany
Asia Pacific
China
Japan
Latin America
Brazil
Mexico
MEA
South Africa
Saudi Arabia
b. The global pharmaceutical cartridges market size was estimated at USD 1,081.09 million in 2019 and is expected to reach USD 1,164.34 million in 2020.
b. The global pharmaceutical cartridges market is expected to grow at a compound annual growth rate of 7.8% from 2018 to 2026 to reach USD 1,834.86 million by 2026.
b. North America dominated the pharmaceutical cartridges market with a share of 31.0% in 2018. This is attributable to rising healthcare awareness coupled with the rising prevalence of chronic conditions.
b. Some key players operating in the pharmaceutical cartridges market include Gerresheimer AG; SCHOTT AG; West Pharmaceutical Services, Inc.; Merck KGaA; Stevanto Group; Transcoject GmbH; and Baxter International, Inc.
b. Key factors that are driving the market growth include the rising prevalence of chronic conditions, such as diabetes and arthritis, and various advantages offered by pharmaceutical cartridges over the traditional ones.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
Multiple therapeutic regimens are being followed across the globe in attempts to come up with a reliable treatment for Covid-19. One line of treatment includes the use of hydroxychloroquine, while a second treatment line focuses to use antiviral drugs used in the disease management of HIV. Both these approaches have surged demand from advanced antivirals and antimalarial drugs. This impacts the drug manufacturers as an off label indication for these drug classes has to be worked upon. At the moment, the WHO has not prescribed any of these approaches, neither they have commented if one is better than the other. The report will account for Covid19 as a key market contributor.
We value your investment and offer free customization with every report to fulfil your exact research needs.